Wednesday, May 18, 2016

BRIEF-Aveo Pharmaceuticals announces closing of private placement and amended term loan

* Announces closing of private placement and amended term

loan to fund pivotal Tivo 3 trial and combination PD-1 trial of

tivozanib in renal cell cancer

Read more

No comments:

Post a Comment